4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
U.S. Biotech Companies Increasingly Keep Discoveries Confidential
U.S. biotech companies are increasingly opting to keep their discoveries confidential due to concerns about competition from Chinese firms. This strategy is intended to safeguard intellectual property and maintain market advantage.
Our neutral summary
U.S. biotech companies are increasingly opting to keep their discoveries confidential due to concerns about competition from Chinese firms. This strategy is intended to safeguard intellectual property and maintain market advantage.
Read the full story at New York Times — Business ↗
The reporting belongs to
New York Times — Business;
we don't reproduce it.